title: [Screening of prostate carcinoma].
abstract: Taking into consideration the height costs of screening healthy men from general population at risk for prostate cancer, we do not recommend prostate cancer screening except for scientific reasons in prospective random trials. To diagnose prostate cancer we know the following methods for patients with prostatic problems: DRE = (digital rectal examination) PSA = (prostate-specific antigen) TRUS = (transrectal ultrasonography) The possible validity of DRE, PSA and TRUS are discussed. The best and most economic way of diagnosing prostate cancer is a combination of DRE and PSA.
authors.affiliation: Urologische Klinik, Universitätsspital Zürich.
authors.forename: F B
authors.initials: FB
authors.lastname: Trinkler
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D003362:Cost-Benefit Analysis; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000191:economics; D008875:Middle Aged; D010173:Palpation; D017430:Prostate-Specific Antigen / Q000302:isolation & purification; D011471:Prostatic Neoplasms / Q000175:diagnosis*; D012007:Rectum; D014463:Ultrasonography / Q000379:methods
chemical_list: D017430:Prostate-Specific Antigen